| Scientific Name |
Nilotinib
|
|---|---|
| Brand Name |
Tasigna
|
| Risk |
Risk of hepatitis B reactivation, QT prolongation, Cardiovascular events, Hepatic transaminase and bilirubin elevations, Uncontrolled or significant cardiac disease/cardiac failure.Uncontrolled or significant cardiac disease/cardiac failure, atherosclerosis-related diseases.
|
| Educational Materials for Healthcare Professionals |
|
| Dear Healthcare Professional Communication (DHPC) for Healthcare Professionals |
|
| Educational Materials for Patients |
|